Three strikes and kids’ cancer is out

Pediatric PRVs and other provisions to support pediatric drug development were stripped out of an eleventh-hour spending bill passed by the U.S. House of Representatives on Friday evening to avoid a government shutdown. 

It is the House’s third attempt at a spending bill — one that also cut out PBM reform and provisions that would restrict some investments in Chinese technology. The Biosecure Act never made it into the first bill...